Steen Solution™

DEVICE2 trials

Sponsors

University of North Carolina, Chapel Hill

Conditions

Alpha-1 Antitrypsin DeficiencyBronchiectasisChronic Obstructive Pulmonary Disease (COPD)Cystic FibrosisEmphysemaPulmonary FibrosisPulmonary HypertensionSarcoidosis

Unknown Phase

Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant Suitability

TerminatedNCT01241942

University of North Carolina, Chapel HillAlpha-1 Antitrypsin Deficiency, Bronchiectasis, Chronic Obstructive Pulmonary Disease (COPD) +5

Start: 2010-12-31End: 2013-03-31Updated: 2018-07-13

Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability

CompletedNCT01615484

University of North Carolina, Chapel HillAlpha-1 Antitrypsin Deficiency, Bronchiectasis, Chronic Obstructive Pulmonary Disease (COPD) +5

Start: 2013-09-30End: 2017-01-31Updated: 2018-06-08

Related Papers

Assessment of Lungs for Transplant Recovered from Uncontrolled Donation after Circulatory Determination of Death Donors

Annals of the American Thoracic Society2017-09-0117 citations